3/3
08:25 pm
cgen
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Low
Report
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
3/2
07:16 am
cgen
Compugen Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
High
Report
Compugen Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
3/2
07:00 am
cgen
Compugen Reports Fourth Quarter and Full Year 2025 Results
High
Report
Compugen Reports Fourth Quarter and Full Year 2025 Results
2/27
07:38 am
cgen
Compugen Ltd (CGEN) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Compugen Ltd (CGEN) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/19
07:00 am
cgen
Compugen to Participate in Upcoming Investor Conferences
Medium
Report
Compugen to Participate in Upcoming Investor Conferences
2/17
07:00 am
cgen
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026
Low
Report
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026
2/12
07:00 am
cgen
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors
Medium
Report
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors
1/8
06:15 am
cgen
Compugen (NASDAQ:CGEN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Medium
Report
Compugen (NASDAQ:CGEN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/7
07:08 am
cgen
Compugen (NASDAQ:CGEN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Compugen (NASDAQ:CGEN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
12/17
07:46 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
High
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
12/17
07:00 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Low
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million